DGX
Quest Diagnostics Incorporated
NYSE · Healthcare · Medical - Diagnostics & Research · US
$237.58
−0.76%Aug 25, 2026, 12:00 UTC
Humanity Health Inc. launched its Humanity Biological Age analysis in the United States through Quest Diagnostics' consumer-initiated testing platform questhealth.com.
Source:Aug 18, 2026, 17:55 UTC
Whoop announced that its Advanced Labs health screenings no longer require a subscription, and added the multi-cancer early detection test Galleri to its portfolio.
Source:Aug 12, 2026, 20:15 UTC
Quest Diagnostics' Board of Directors declared a quarterly cash dividend of $0.86 per share, payable on October 21, 2026, to shareholders of record on October 6, 2026.
Source:Aug 4, 2026, 19:00 UTC
Cassandra Barksdale filed a personal injury lawsuit in the State Court of Clayton County against Kaiser Foundation Health Plan of Georgia, Inc., Kaiser Foundation Health Plan, Inc., Kaiser Permanente Insurance Company, and Cecelia Prestridge, alleging a mislabeled tissue sample led to an unnecessary total hysterectomy.
Jul 23, 2026, 10:54 UTC
Quest Diagnostics reported its fiscal 2026 second-quarter (April-June) financial results, showing revenue of $3.043 billion, operating income of $459 million, and diluted EPS of $2.86.
Jul 8, 2026, 12:52 UTC
Quest Diagnostics launches a pilot program integrating its Haystack MRD ctDNA test and Comprehensive Genomic Profiling services into OncoEMR EHR for community oncology providers including American Oncology Network.
Source:Jun 24, 2026, 12:52 UTC
Quest Diagnostics received approval from the New York State Department of Health's Clinical Laboratory Evaluation Program for its Haystack MRD test.
Source:Jun 23, 2026, 23:45 UTC
The US Court of Appeals for the Third Circuit ruled in favor of Quest Diagnostics, rejecting a class-action lawsuit by employees alleging mishandling of the company's 401(k) retirement plan.
Source:Jun 16, 2026, 00:00 UTC
GeneDx Holdings Corp. appointed Mark Gardner as President, effective June 15, 2026.
Source: